N

Neurosterix

HealthNeuroscience

Neurosterix, a spin-out from Addex, has successfully closed a $105 million Series B financing round. The company is focused on developing novel therapeutics for neurological disorders.

Total raised
Undisclosed
tracked to date
Latest round
Series B
Nov 11, 2026
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups.

Claim this profile →

Funding history

  1. 1
    $105 MillionSeries BNov 11, 2026
    Announcement ↗

Neurosterix in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile